IP Library Granted Patent US 7,316,644
Granted Patent B2
US 7,316,644 · App. 11/198,873 · Granted Jan 8, 2008

Method for preparing particles of radioactive powder containing Cesium-131 for use in brachytherapy sources

Assignee: IsoRay Medical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,316,644
App. No.
11/198,873
Granted
Jan 8, 2008
Kind
B2
Abstract

The present invention provides a method of preparing Cesium-131 (Cs-131) as a dispersed radioisotope. Uses of the dispersed Cs-131 prepared by the method include cancer research and treatment, such as for the use in brachytherapy. Cs-131 is particularly useful in the treatment of faster growing tumors.

Claims (12)

1. A method for preparing particles of radioactive powder containing Cs-131, comprising the step of contacting Cs-131 with a material to produce microparticles of radioactive powder containing Cs-131, wherein the material comprises a crystalline silicotitanate and an aluminosilicate.

2. The method of claim 1 wherein the material consists of a crystalline silicotitanate and an aluminosilicate.

3. The method of claim 1 further comprising exposing the radioactive particles to a bonding agent, whereby the agent increases the retention of the Cs-131 by the particles.

4. The method of claim 3 wherein the bonding agent is heat.

5. A method for preparing a brachytherapy device, comprising the step of dispersing the radioactive particles prepared according to the method of any one of claims 1 - 4 in an organic, polymeric or inorganic matrix.

6. A brachytherapy device, comprising a device prepared according to the method of claim 5 .

7. A method of treating a tumor susceptible to radiation from Cs-131, comprising the step of subjecting the tumor to the brachytherapy device of claim 6 .

8. A brachytherapy device, comprising microparticles of radioactive powder containing Cs-131, wherein the microparticles comprise Cs-131 and a crystalline silicotitanate and an aluminosilicate.

9. The brachytherapy device of claim 8 wherein the microparticles consist of Cs-131, a crystalline silicotitanate and an aluminosilicate.

10. The brachytherapy device of claim 8 or 9 wherein the microparticles are dispersed in an organic, polymeric or inorganic matrix.

11. A method of treating a tumor susceptible to radiation from Cs-131, comprising the step of subjecting the tumor to the brachytherapy device of claim 8 or claim 9 .

12. A method of treating a tumor susceptible to radiation from Cs-131, comprising the step of subjecting the tumor to the brachytherapy device of claim 10 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2024
From: ISORAY MEDICAL, INC.
To: GT MEDICAL TECHNOLOGIES, INC.
Reel/Frame 068158/0875 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2005
From: BRAY, LANE ALLAN
To: ISORAY MEDICAL, INC.
Reel/Frame 016853/0562 →
Continuity (3)
Provisional Application 6062612300 · Nov 9, 2004
Provisional Application 6060239200 · Aug 18, 2004
Related Publication 20060167332A1 · Jul 27, 2006